“…Furthermore, due to the high enzyme loading capacity, biodegradability, and high biocompatibility in vitro and in vivo, multi-enzyme@MOF systems have also shown considerable promise in catalytic nanomedicine applications, such as glucose oxidase (GOx) and horseradish peroxidase (HRP) or chloroperoxidase (CPO) co-encapsulated in MOFs induced high toxic reactive oxygen species (ROS) generation for tumor cell therapy, [44,45] and GOx and catalase co-immobilized within MOFs enabled smart drug delivery with negligible cytotoxicity. [54] In addition, with extraordinary chemical robustness and high enzyme encapsulation capacity of MOFs, the multi-enzyme@MOF systems allow new possibilities in artificial and hybrid cells design, enabling new potentials in cell manipulation and enzyme replacement therapy. [47,57] Although a series of review articles on the diversity of enzymatic cascades [1,[58][59][60][61][62] and their immobilization in macromolecular scaffolds have been published within the past few years, [9,18,21,22,31,[63][64][65][66][67][68][69] none has particularly focused on the immobilization strategies of multi-enzyme within MOFs and their cutting-edge applications.…”